BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 21530968)

  • 1. Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization.
    Kaneko H; Anzai T; Morisawa M; Kohno T; Nagai T; Anzai A; Takahashi T; Shimoda M; Sasaki A; Maekawa Y; Yoshimura K; Aoki H; Tsubota K; Yoshikawa T; Okada Y; Ogawa S; Fukuda K
    Atherosclerosis; 2011 Aug; 217(2):350-7. PubMed ID: 21530968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm.
    Kaneko H; Anzai T; Takahashi T; Kohno T; Shimoda M; Sasaki A; Shimizu H; Nagai T; Maekawa Y; Yoshimura K; Aoki H; Yoshikawa T; Okada Y; Yozu R; Ogawa S; Fukuda K
    Cardiovasc Res; 2011 Jul; 91(2):358-67. PubMed ID: 21436157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of abdominal aortic aneurysm formation by inhibition of prolyl hydroxylase domain protein through attenuation of inflammation and extracellular matrix disruption.
    Watanabe A; Ichiki T; Sankoda C; Takahara Y; Ikeda J; Inoue E; Tokunou T; Kitamoto S; Sunagawa K
    Clin Sci (Lond); 2014 May; 126(9):671-8. PubMed ID: 24256203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-α converting enzyme is a key mediator of abdominal aortic aneurysm development.
    Kaneko H; Anzai T; Horiuchi K; Kohno T; Nagai T; Anzai A; Takahashi T; Sasaki A; Shimoda M; Maekawa Y; Shimizu H; Yoshikawa T; Okada Y; Yozu R; Fukuda K
    Atherosclerosis; 2011 Oct; 218(2):470-8. PubMed ID: 21722904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azelnidipine suppresses the progression of aortic aneurysm in wild mice model through anti-inflammatory effects.
    Kurobe H; Matsuoka Y; Hirata Y; Sugasawa N; Maxfield MW; Sata M; Kitagawa T
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1501-8. PubMed ID: 23535154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage-derived angiopoietin-like protein 2 accelerates development of abdominal aortic aneurysm.
    Tazume H; Miyata K; Tian Z; Endo M; Horiguchi H; Takahashi O; Horio E; Tsukano H; Kadomatsu T; Nakashima Y; Kunitomo R; Kaneko Y; Moriyama S; Sakaguchi H; Okamoto K; Hara M; Yoshinaga T; Yoshimura K; Aoki H; Araki K; Hao H; Kawasuji M; Oike Y
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1400-9. PubMed ID: 22556334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free-radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats.
    Morimoto K; Hasegawa T; Tanaka A; Wulan B; Yu J; Morimoto N; Okita Y; Okada K
    J Vasc Surg; 2012 Jun; 55(6):1749-58. PubMed ID: 22341578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally administered dipeptidyl peptidase-4 inhibitor (alogliptin) prevents abdominal aortic aneurysm formation through an antioxidant effect in rats.
    Bao W; Morimoto K; Hasegawa T; Sasaki N; Yamashita T; Hirata K; Okita Y; Okada K
    J Vasc Surg; 2014 Apr; 59(4):1098-108. PubMed ID: 23790558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous superoxide dismutase activation by oral administration of riboflavin reduces abdominal aortic aneurysm formation in rats.
    Yu Z; Morimoto K; Yu J; Bao W; Okita Y; Okada K
    J Vasc Surg; 2016 Sep; 64(3):737-45. PubMed ID: 26070605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm.
    Usui F; Shirasuna K; Kimura H; Tatsumi K; Kawashima A; Karasawa T; Yoshimura K; Aoki H; Tsutsui H; Noda T; Sagara J; Taniguchi S; Takahashi M
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):127-36. PubMed ID: 25378412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane-Bound Thrombomodulin Regulates Macrophage Inflammation in Abdominal Aortic Aneurysm.
    Wang KC; Li YH; Shi GY; Tsai HW; Luo CY; Cheng MH; Ma CY; Hsu YY; Cheng TL; Chang BI; Lai CH; Wu HL
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2412-22. PubMed ID: 26338301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine (C-X-C motif) receptor 4 blockade by AMD3100 inhibits experimental abdominal aortic aneurysm expansion through anti-inflammatory effects.
    Michineau S; Franck G; Wagner-Ballon O; Dai J; Allaire E; Gervais M
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1747-55. PubMed ID: 24876351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol counteracts systemic and local inflammation involved in early abdominal aortic aneurysm development.
    Palmieri D; Pane B; Barisione C; Spinella G; Garibaldi S; Ghigliotti G; Brunelli C; Fulcheri E; Palombo D
    J Surg Res; 2011 Dec; 171(2):e237-46. PubMed ID: 21962734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse model.
    Spinosa M; Su G; Salmon MD; Lu G; Cullen JM; Fashandi AZ; Hawkins RB; Montgomery W; Meher AK; Conte MS; Sharma AK; Ailawadi G; Upchurch GR
    J Vasc Surg; 2018 Dec; 68(6S):93S-103S. PubMed ID: 30470363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermedin1-53 Attenuates Abdominal Aortic Aneurysm by Inhibiting Oxidative Stress.
    Lu WW; Jia LX; Ni XQ; Zhao L; Chang JR; Zhang JS; Hou YL; Zhu Y; Guan YF; Yu YR; Du J; Tang CS; Qi YF
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2176-2190. PubMed ID: 27634835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergic Lung Inflammation Aggravates Angiotensin II-Induced Abdominal Aortic Aneurysms in Mice.
    Liu CL; Wang Y; Liao M; Wemmelund H; Ren J; Fernandes C; Zhou Y; Sukhova GK; Lindholt JS; Johnsen SP; Zhang JY; Cheng X; Huang X; Daugherty A; Levy BD; Libby P; Shi GP
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):69-77. PubMed ID: 26543094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release of ascorbic acid from gelatin hydrogel attenuates abdominal aortic aneurysm formation in rat experimental abdominal aortic aneurysm model.
    Tanaka A; Hasegawa T; Morimoto K; Bao W; Yu J; Okita Y; Tabata Y; Okada K
    J Vasc Surg; 2014 Sep; 60(3):749-58. PubMed ID: 24011462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway.
    Tsai SH; Huang PH; Peng YJ; Chang WC; Tsai HY; Leu HB; Chen JW; Lin SJ
    Cardiovasc Res; 2013 Dec; 100(3):501-10. PubMed ID: 24225494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside Rb1 attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the JNK and p38 signaling pathways.
    Zhang XJ; He C; Tian K; Li P; Su H; Wan JB
    Vascul Pharmacol; 2015 Oct; 73():86-95. PubMed ID: 25912763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antioxidant Vitamin C attenuates experimental abdominal aortic aneurysm development in an elastase-induced rat model.
    Shang T; Liu Z; Liu CJ
    J Surg Res; 2014 May; 188(1):316-25. PubMed ID: 24484904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.